chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: U
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: Administrative deviation only; no adverse event resulted from this deviation. This patient received a  mixed series  of COVID-19 vaccine (one dose of Moderna and one dose of Pfizer-box#4 reflects the date  of the second dose).The decision to administer a mixed series to the patient was due to an "exceptional  circumstance" stemming form the unavailability of of the first vaccine product (Moderna) at the time the second dose was due.We understand that although CDC provides considerations for a mixed series in  exceptional circumstances (such as a vaccine shortage, which was the case here), a mixed series is still considered an administration deviation that requires reporting.Note second vaccination date is listed.
Age: 42.0
Sex: U
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: Administration deviation only; no adverse event resulted from this deviation.This patient received a mixed series of COVID-19 vaccine (one does of Moderna and one dose of Pfizer-box#4 reflects the date  of the second dose). The decision to administer a mixed series to the patient was due to an "exceptional circumstance" stemming from the unavailability of the first vaccine product (Moderna) at the time the second dose was used.We understand that although CDC provides considerations for a mixed series in exceptional circumstances (such as a vaccine shortage, which was the case here), a mixed series is still considered an administration deviation that requires reporting:Note second vaccination date is  listed.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Chills, Dyspnoea, Eye swelling, Headache
Clinical narrative: I had a severe case of Anaphylaxis - both eyes swollen 20 hours after second vaccine taken - restless - problem with breathing - high fever - headache and chills
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Restlessness
Clinical narrative: I had a severe case of Anaphylaxis - both eyes swollen 20 hours after second vaccine taken - restless - problem with breathing - high fever - headache and chills
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Varicocele, Varicose vein
Clinical narrative: Varicocele And worsened low extremity vericose veins following second dose of Pfizer COVID vaccine on May 2 2021. First dose was injected at the beginning of April 2021
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Heavy menstrual bleeding, Menstruation irregular, Nausea
Clinical narrative: I have always had regular menstrual periods until I received my 2nd dose of the Pfizer covid vaccine in June. Now my periods are extremely heavy and occur at unusual times. I also get nausea and cramping which I never had before.
Sex: U
Vaccine: COVID19
Symptoms: Condition aggravated, Headache, Hemiparesis, Memory impairment, Multiple sclerosis
Clinical narrative: A week after 2nd Pfizer vaccine old MS symptoms reoccurred.Thoracic radiculopathy, increased R side weakness, forgetfulness, bad headaches. improved somewhat. Now have ringing in ears-new symptom.
Sex: U
Vaccine: COVID19
Symptoms: Thoracic radiculopathy, Tinnitus
Clinical narrative: A week after 2nd Pfizer vaccine old MS symptoms reoccurred.Thoracic radiculopathy, increased R side weakness, forgetfulness, bad headaches. improved somewhat. Now have ringing in ears-new symptom.
Sex: F
Vaccine: COVID19
Symptoms: Adnexa uteri pain, Adnexal torsion, Bronchitis, Computerised tomogram, Intra-abdominal fluid collection
Clinical narrative: I got the first injection of the Pfizer vaccine for Covid and was throwing up for three days then got, what was thought to be, bronchitis out of no where (the doctor said she couldn't explain it since it usually comes on slowly and this came on in a matter in seconds. Literally). I then ended up in the emergency room with the worst pain of my life. They found multiple cysts on one of my ovaries (that I've never had on that ovary in my 48 years of life), and a lot of fluid in my pelvis (that they think means I may have had a much larger cyst rupture) and also found my ovary to be 5 times it's normal size, AND it twisted due to the size of another cyst. There is no doubt that the vaccine caused this due to the timing. After my second dose, I got lock jaw, and my throat was tight. Now I'm having pain again in my ovaries. Please, please, please do NOT approve this vaccine. I have a friend who went blind three hours after the Pfizer and another friend who was hospitalized for 5 days due to a severe case of shingles (both have been reported to the CDC). This is HORRIBLE.
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Ovarian cyst, Ovarian cyst ruptured, Ovarian enlargement, Pain
Clinical narrative: I got the first injection of the Pfizer vaccine for Covid and was throwing up for three days then got, what was thought to be, bronchitis out of no where (the doctor said she couldn't explain it since it usually comes on slowly and this came on in a matter in seconds. Literally). I then ended up in the emergency room with the worst pain of my life. They found multiple cysts on one of my ovaries (that I've never had on that ovary in my 48 years of life), and a lot of fluid in my pelvis (that they think means I may have had a much larger cyst rupture) and also found my ovary to be 5 times it's normal size, AND it twisted due to the size of another cyst. There is no doubt that the vaccine caused this due to the timing. After my second dose, I got lock jaw, and my throat was tight. Now I'm having pain again in my ovaries. Please, please, please do NOT approve this vaccine. I have a friend who went blind three hours after the Pfizer and another friend who was hospitalized for 5 days due to a severe case of shingles (both have been reported to the CDC). This is HORRIBLE.
Sex: F
Vaccine: COVID19
Symptoms: Throat tightness, Trismus, Ultrasound scan, Vomiting
Clinical narrative: I got the first injection of the Pfizer vaccine for Covid and was throwing up for three days then got, what was thought to be, bronchitis out of no where (the doctor said she couldn't explain it since it usually comes on slowly and this came on in a matter in seconds. Literally). I then ended up in the emergency room with the worst pain of my life. They found multiple cysts on one of my ovaries (that I've never had on that ovary in my 48 years of life), and a lot of fluid in my pelvis (that they think means I may have had a much larger cyst rupture) and also found my ovary to be 5 times it's normal size, AND it twisted due to the size of another cyst. There is no doubt that the vaccine caused this due to the timing. After my second dose, I got lock jaw, and my throat was tight. Now I'm having pain again in my ovaries. Please, please, please do NOT approve this vaccine. I have a friend who went blind three hours after the Pfizer and another friend who was hospitalized for 5 days due to a severe case of shingles (both have been reported to the CDC). This is HORRIBLE.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac disorder
Clinical narrative: The Pfizer vaccine was administered and heart problems began shortly after. Hospitalized 3 times since.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test normal, Magnetic resonance imaging normal, Neuropathy peripheral, Paraesthesia, Vitamin B6 increased
Clinical narrative: Tingling in feet, hands, arms, legs, scalp and face; Tingling in feet; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (Tingling in feet, hands, arms, legs, scalp and face) and PARAESTHESIA (Tingling in feet) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2020, the patient experienced PARAESTHESIA (Tingling in feet). On 12-Feb-2021, the patient experienced PARAESTHESIA (Tingling in feet, hands, arms, legs, scalp and face). On 05-Feb-2021, PARAESTHESIA (Tingling in feet) had resolved. At the time of the report, PARAESTHESIA (Tingling in feet, hands, arms, legs, scalp and face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment details were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: TCR form received on 11-MAY-2021 contains non-significant information.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling in feet, hands, arms, legs, scalp and face; Tingling in feet; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (Tingling in feet, hands, arms, legs, scalp and face) and PARAESTHESIA (Tingling in feet) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2020, the patient experienced PARAESTHESIA (Tingling in feet). On 12-Feb-2021, the patient experienced PARAESTHESIA (Tingling in feet, hands, arms, legs, scalp and face). On 05-Feb-2021, PARAESTHESIA (Tingling in feet) had resolved. At the time of the report, PARAESTHESIA (Tingling in feet, hands, arms, legs, scalp and face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment details were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: TCR form received on 11-MAY-2021 contains non-significant information.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Found deceased next morning after vaccine.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pulmonary thrombosis, Respiratory arrest, SARS-CoV-2 test
Clinical narrative: Pulmonary Embolism x multiple, one as long as 4". Pulmonary angiogram and resection. Now on Xarelto permanently Mixed Connective Tissue Disease. Now on hydroxychloroquine
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Anticoagulant therapy, Blood test, Mixed connective tissue disease, Pulmonary embolism
Clinical narrative: Pulmonary Embolism x multiple, one as long as 4". Pulmonary angiogram and resection. Now on Xarelto permanently Mixed Connective Tissue Disease. Now on hydroxychloroquine
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pulmonary resection
Clinical narrative: Pulmonary Embolism x multiple, one as long as 4". Pulmonary angiogram and resection. Now on Xarelto permanently Mixed Connective Tissue Disease. Now on hydroxychloroquine
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Arthralgia, Back pain, Blood pressure increased, Blood test
Clinical narrative: site reaction of soreness to the left arm, swollen lymph node to left arm, rash on left arm that spread down the arm and then the patient had pain in her chest that radiated to her mid upper back a few days prior to her going to the ER due to pain and elevated BP. At the time of the ER visit on 3/11/21 she was diagnosed with a PE.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Breast pain, Breast swelling, Chest X-ray, Chest pain, Chills
Clinical narrative: site reaction of soreness to the left arm, swollen lymph node to left arm, rash on left arm that spread down the arm and then the patient had pain in her chest that radiated to her mid upper back a few days prior to her going to the ER due to pain and elevated BP. At the time of the ER visit on 3/11/21 she was diagnosed with a PE.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Dyspnoea, Electrocardiogram, Headache, Injection site pain
Clinical narrative: site reaction of soreness to the left arm, swollen lymph node to left arm, rash on left arm that spread down the arm and then the patient had pain in her chest that radiated to her mid upper back a few days prior to her going to the ER due to pain and elevated BP. At the time of the ER visit on 3/11/21 she was diagnosed with a PE.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Joint swelling, Pain, Pain in extremity, Peripheral swelling, Pulmonary embolism
Clinical narrative: site reaction of soreness to the left arm, swollen lymph node to left arm, rash on left arm that spread down the arm and then the patient had pain in her chest that radiated to her mid upper back a few days prior to her going to the ER due to pain and elevated BP. At the time of the ER visit on 3/11/21 she was diagnosed with a PE.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash pruritic
Clinical narrative: site reaction of soreness to the left arm, swollen lymph node to left arm, rash on left arm that spread down the arm and then the patient had pain in her chest that radiated to her mid upper back a few days prior to her going to the ER due to pain and elevated BP. At the time of the ER visit on 3/11/21 she was diagnosed with a PE.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Blood pressure increased, Chest pain, Computerised tomogram abnormal, Electrocardiogram
Clinical narrative: site reaction of soreness to the left arm, swollen lymph node to left arm, rash on left arm that spread down the arm and then the patient had pain in her chest that radiated to her mid upper back a few days prior to her going to the ER due to pain and elevated BP. At the time of the ER visit on 3/11/21 she was diagnosed with a PE.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram ambulatory, Fibrin D dimer, Full blood count, Lipase, Lymphadenopathy
Clinical narrative: site reaction of soreness to the left arm, swollen lymph node to left arm, rash on left arm that spread down the arm and then the patient had pain in her chest that radiated to her mid upper back a few days prior to her going to the ER due to pain and elevated BP. At the time of the ER visit on 3/11/21 she was diagnosed with a PE.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test, Pain, Pain in extremity, Rash, Troponin
Clinical narrative: site reaction of soreness to the left arm, swollen lymph node to left arm, rash on left arm that spread down the arm and then the patient had pain in her chest that radiated to her mid upper back a few days prior to her going to the ER due to pain and elevated BP. At the time of the ER visit on 3/11/21 she was diagnosed with a PE.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram, Bell's palsy, Facial paralysis, Fall, Magnetic resonance imaging normal
Clinical narrative: Diagnosed with Guillan-Barrae
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Guillain-Barre syndrome, Laboratory test
Clinical narrative: Diagnosed with Guillan-Barrae
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Guillain-Barre syndrome
Clinical narrative: Diagnosed with Guillan-Barrae
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Aphasia, Cerebrovascular accident, Clumsiness, Computerised tomogram, Echocardiogram
Clinical narrative: Ischemic Stroke - Tissue Plasminogen Activator (TPA)  - Administered in ER - spent 2 days in Intensive Care Outcome, stroke resolved, limited side effects, however: Second Stroke  occurred April 26th - (11 days after first stroke), Resolved itself - spent 2 more days in hospital
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Intensive care, Magnetic resonance imaging, Muscular weakness
Clinical narrative: Ischemic Stroke - Tissue Plasminogen Activator (TPA)  - Administered in ER - spent 2 days in Intensive Care Outcome, stroke resolved, limited side effects, however: Second Stroke  occurred April 26th - (11 days after first stroke), Resolved itself - spent 2 more days in hospital
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Illness
Clinical narrative: Ischemic Stroke - Tissue Plasminogen Activator (TPA)  - Administered in ER - spent 2 days in Intensive Care Outcome, stroke resolved, limited side effects, however: Second Stroke  occurred April 26th - (11 days after first stroke), Resolved itself - spent 2 more days in hospital
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Intensive care, Ischaemic stroke, Laboratory test, Magnetic resonance imaging head abnormal
Clinical narrative: Ischemic Stroke - Tissue Plasminogen Activator (TPA)  - Administered in ER - spent 2 days in Intensive Care Outcome, stroke resolved, limited side effects, however: Second Stroke  occurred April 26th - (11 days after first stroke), Resolved itself - spent 2 more days in hospital
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Diarrhoea, Ear pain, Headache, Hypoacusis
Clinical narrative: I felt really jittery right after the vaccine. I was trying to talk and it was like I couldn't talk properly. I was having brain fog pretty bad. The brain fog thing was happening for awhile. It eventually went away. I felt sore in my joints and stuff like that. I went outside to do some yard work and I started shaking really bad. My husband brought me some water and the water couldn't even stay in the cup because I was shaking so bad. I noticed that my arm started to swell pretty bad and it hurt tremendously. I went in and saw my PCP and he sent me to the ER to get an ultrasound done. They found blood clots in my arm. I was sent to a hematologist.  I was put on Eliquis. 2 weeks later, I went back in and they did more blood work. I just went in recently and they did blood work again. They told me to finish the bottle that I'm on and they want to see me again 11/16. I believe that day they are going to do more blood work.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Musculoskeletal stiffness, Nausea, Pyrexia, Tinnitus
Clinical narrative: I felt really jittery right after the vaccine. I was trying to talk and it was like I couldn't talk properly. I was having brain fog pretty bad. The brain fog thing was happening for awhile. It eventually went away. I felt sore in my joints and stuff like that. I went outside to do some yard work and I started shaking really bad. My husband brought me some water and the water couldn't even stay in the cup because I was shaking so bad. I noticed that my arm started to swell pretty bad and it hurt tremendously. I went in and saw my PCP and he sent me to the ER to get an ultrasound done. They found blood clots in my arm. I was sent to a hematologist.  I was put on Eliquis. 2 weeks later, I went back in and they did more blood work. I just went in recently and they did blood work again. They told me to finish the bottle that I'm on and they want to see me again 11/16. I believe that day they are going to do more blood work.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Arthralgia, Blood test, Feeling abnormal, Feeling jittery
Clinical narrative: I felt really jittery right after the vaccine. I was trying to talk and it was like I couldn't talk properly. I was having brain fog pretty bad. The brain fog thing was happening for awhile. It eventually went away. I felt sore in my joints and stuff like that. I went outside to do some yard work and I started shaking really bad. My husband brought me some water and the water couldn't even stay in the cup because I was shaking so bad. I noticed that my arm started to swell pretty bad and it hurt tremendously. I went in and saw my PCP and he sent me to the ER to get an ultrasound done. They found blood clots in my arm. I was sent to a hematologist.  I was put on Eliquis. 2 weeks later, I went back in and they did more blood work. I just went in recently and they did blood work again. They told me to finish the bottle that I'm on and they want to see me again 11/16. I believe that day they are going to do more blood work.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Peripheral swelling, Speech disorder, Thrombosis, Tremor
Clinical narrative: I felt really jittery right after the vaccine. I was trying to talk and it was like I couldn't talk properly. I was having brain fog pretty bad. The brain fog thing was happening for awhile. It eventually went away. I felt sore in my joints and stuff like that. I went outside to do some yard work and I started shaking really bad. My husband brought me some water and the water couldn't even stay in the cup because I was shaking so bad. I noticed that my arm started to swell pretty bad and it hurt tremendously. I went in and saw my PCP and he sent me to the ER to get an ultrasound done. They found blood clots in my arm. I was sent to a hematologist.  I was put on Eliquis. 2 weeks later, I went back in and they did more blood work. I just went in recently and they did blood work again. They told me to finish the bottle that I'm on and they want to see me again 11/16. I believe that day they are going to do more blood work.
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ultrasound Doppler abnormal
Clinical narrative: I felt really jittery right after the vaccine. I was trying to talk and it was like I couldn't talk properly. I was having brain fog pretty bad. The brain fog thing was happening for awhile. It eventually went away. I felt sore in my joints and stuff like that. I went outside to do some yard work and I started shaking really bad. My husband brought me some water and the water couldn't even stay in the cup because I was shaking so bad. I noticed that my arm started to swell pretty bad and it hurt tremendously. I went in and saw my PCP and he sent me to the ER to get an ultrasound done. They found blood clots in my arm. I was sent to a hematologist.  I was put on Eliquis. 2 weeks later, I went back in and they did more blood work. I just went in recently and they did blood work again. They told me to finish the bottle that I'm on and they want to see me again 11/16. I believe that day they are going to do more blood work.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Full blood count, Immunoglobulin therapy, Thrombocytopenic purpura
Clinical narrative: There have been two other VAERS submitted for previous hospital visits. The first was 3/23/21  9-10 days after her vaccination when she presented with  purpura on lower extremities extending backwards to abdomen. large ecchymosis on bilateral arms. Platelet count of 1,000. Treated with dexamethasone and IVIG. Discharged with platelet count of 68,000.    Second was 4/15/21 when she was sent to hospital after outpatient lab indicated platelet count of 21,000. Treated with IVIG & rituxan.  Cellulitis of left forearm also treated.  Discharged on augmentin and IVIG/rituxan outpatient infusion therapy.  She returned to hospital on 4/26/21 for worsening cellulitis.  Wound was debrided and she was discharged after improvement  Her last hospital visit on record was 5/17/21 when she presented to ED with left arm and leg weakness and blurry vision.  Symptoms had started the prior evening around 8PM.  Provider evaluated patient (head CT, labs, urine).  Head CT was negative, and determined that there were no significant abnormalities in labs or imaging to suggest dangerous cause of symptoms. Patient was discharged and advissed to return for any new or worsening symptoms. No further visits on record.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cellulitis, Computerised tomogram head normal, Debridement, Ecchymosis, Hemiparesis
Clinical narrative: There have been two other VAERS submitted for previous hospital visits. The first was 3/23/21  9-10 days after her vaccination when she presented with  purpura on lower extremities extending backwards to abdomen. large ecchymosis on bilateral arms. Platelet count of 1,000. Treated with dexamethasone and IVIG. Discharged with platelet count of 68,000.    Second was 4/15/21 when she was sent to hospital after outpatient lab indicated platelet count of 21,000. Treated with IVIG & rituxan.  Cellulitis of left forearm also treated.  Discharged on augmentin and IVIG/rituxan outpatient infusion therapy.  She returned to hospital on 4/26/21 for worsening cellulitis.  Wound was debrided and she was discharged after improvement  Her last hospital visit on record was 5/17/21 when she presented to ED with left arm and leg weakness and blurry vision.  Symptoms had started the prior evening around 8PM.  Provider evaluated patient (head CT, labs, urine).  Head CT was negative, and determined that there were no significant abnormalities in labs or imaging to suggest dangerous cause of symptoms. Patient was discharged and advissed to return for any new or worsening symptoms. No further visits on record.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immunoglobulin therapy, Infusion, Laboratory test normal, Platelet count decreased, Purpura
Clinical narrative: There have been two other VAERS submitted for previous hospital visits. The first was 3/23/21  9-10 days after her vaccination when she presented with  purpura on lower extremities extending backwards to abdomen. large ecchymosis on bilateral arms. Platelet count of 1,000. Treated with dexamethasone and IVIG. Discharged with platelet count of 68,000.    Second was 4/15/21 when she was sent to hospital after outpatient lab indicated platelet count of 21,000. Treated with IVIG & rituxan.  Cellulitis of left forearm also treated.  Discharged on augmentin and IVIG/rituxan outpatient infusion therapy.  She returned to hospital on 4/26/21 for worsening cellulitis.  Wound was debrided and she was discharged after improvement  Her last hospital visit on record was 5/17/21 when she presented to ED with left arm and leg weakness and blurry vision.  Symptoms had started the prior evening around 8PM.  Provider evaluated patient (head CT, labs, urine).  Head CT was negative, and determined that there were no significant abnormalities in labs or imaging to suggest dangerous cause of symptoms. Patient was discharged and advissed to return for any new or worsening symptoms. No further visits on record.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urine analysis normal, Vision blurred
Clinical narrative: There have been two other VAERS submitted for previous hospital visits. The first was 3/23/21  9-10 days after her vaccination when she presented with  purpura on lower extremities extending backwards to abdomen. large ecchymosis on bilateral arms. Platelet count of 1,000. Treated with dexamethasone and IVIG. Discharged with platelet count of 68,000.    Second was 4/15/21 when she was sent to hospital after outpatient lab indicated platelet count of 21,000. Treated with IVIG & rituxan.  Cellulitis of left forearm also treated.  Discharged on augmentin and IVIG/rituxan outpatient infusion therapy.  She returned to hospital on 4/26/21 for worsening cellulitis.  Wound was debrided and she was discharged after improvement  Her last hospital visit on record was 5/17/21 when she presented to ED with left arm and leg weakness and blurry vision.  Symptoms had started the prior evening around 8PM.  Provider evaluated patient (head CT, labs, urine).  Head CT was negative, and determined that there were no significant abnormalities in labs or imaging to suggest dangerous cause of symptoms. Patient was discharged and advissed to return for any new or worsening symptoms. No further visits on record.
Age: 59.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Cerebrovascular accident, Dysarthria, Dysphagia, Facial paralysis, Laboratory test
Clinical narrative: None stated.
Age: 59.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Magnetic resonance imaging head abnormal
Clinical narrative: None stated.
Age: 59.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Fatigue, Headache, Loss of personal independence in daily activities, Pain
Clinical narrative: Initial arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Initial arm pain) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included Lung transplant (Double lung transplant.).    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (Initial arm pain). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1000 mg three times a day. At the time of the report, PAIN IN EXTREMITY (Initial arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   This case was linked to MOD-2021-215081 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Non-Significant Follow-up received on 19-JUL-2021 and contains no new information
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Headache, Pain
Clinical narrative: Initial arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Initial arm pain) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included Lung transplant (Double lung transplant.).    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (Initial arm pain). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1000 mg three times a day. At the time of the report, PAIN IN EXTREMITY (Initial arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   This case was linked to MOD-2021-215081 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Non-Significant Follow-up received on 19-JUL-2021 and contains no new information
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Blood test, Headache, Neurological examination
Clinical narrative: Initial arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Initial arm pain) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included Lung transplant (Double lung transplant.).    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (Initial arm pain). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1000 mg three times a day. At the time of the report, PAIN IN EXTREMITY (Initial arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   This case was linked to MOD-2021-215081 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Non-Significant Follow-up received on 19-JUL-2021 and contains no new information
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: Initial arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Initial arm pain) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included Lung transplant (Double lung transplant.).    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (Initial arm pain). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1000 mg three times a day. At the time of the report, PAIN IN EXTREMITY (Initial arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   This case was linked to MOD-2021-215081 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Non-Significant Follow-up received on 19-JUL-2021 and contains no new information
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute myocardial infarction, Atrial fibrillation, Bladder neoplasm, Blood cholesterol normal, Blood magnesium normal
Clinical narrative: Urinary issue; Bladder tumor; This spontaneous case was reported by an other health care professional and describes the occurrence of BLADDER NEOPLASM (Bladder tumor) and URINARY TRACT DISORDER (Urinary issue) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced BLADDER NEOPLASM (Bladder tumor). On an unknown date, the patient experienced URINARY TRACT DISORDER (Urinary issue). At the time of the report, BLADDER NEOPLASM (Bladder tumor) and URINARY TRACT DISORDER (Urinary issue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-May-2021, SARS-CoV-2 test: positive positive (Positive) positive. On an unknown date, Blood cholesterol: 195 (Inconclusive) 195. On an unknown date, Blood magnesium: normal (normal) normal. On an unknown date, Blood phosphorus: normal (normal) normal. On an unknown date, Blood triglycerides: 169 (Inconclusive) 169. On an unknown date, Glycosylated haemoglobin: 5.3 (Inconclusive) 5.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-163206 (Patient Link).
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood phosphorus normal, Blood triglycerides increased, COVID-19, Dysuria, Electrocardiogram delta waves abnormal
Clinical narrative: Urinary issue; Bladder tumor; This spontaneous case was reported by an other health care professional and describes the occurrence of BLADDER NEOPLASM (Bladder tumor) and URINARY TRACT DISORDER (Urinary issue) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced BLADDER NEOPLASM (Bladder tumor). On an unknown date, the patient experienced URINARY TRACT DISORDER (Urinary issue). At the time of the report, BLADDER NEOPLASM (Bladder tumor) and URINARY TRACT DISORDER (Urinary issue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-May-2021, SARS-CoV-2 test: positive positive (Positive) positive. On an unknown date, Blood cholesterol: 195 (Inconclusive) 195. On an unknown date, Blood magnesium: normal (normal) normal. On an unknown date, Blood phosphorus: normal (normal) normal. On an unknown date, Blood triglycerides: 169 (Inconclusive) 169. On an unknown date, Glycosylated haemoglobin: 5.3 (Inconclusive) 5.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-163206 (Patient Link).
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Full blood count normal, Glycosylated haemoglobin normal, High density lipoprotein decreased, Low density lipoprotein normal, Metabolic function test normal
Clinical narrative: Urinary issue; Bladder tumor; This spontaneous case was reported by an other health care professional and describes the occurrence of BLADDER NEOPLASM (Bladder tumor) and URINARY TRACT DISORDER (Urinary issue) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced BLADDER NEOPLASM (Bladder tumor). On an unknown date, the patient experienced URINARY TRACT DISORDER (Urinary issue). At the time of the report, BLADDER NEOPLASM (Bladder tumor) and URINARY TRACT DISORDER (Urinary issue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-May-2021, SARS-CoV-2 test: positive positive (Positive) positive. On an unknown date, Blood cholesterol: 195 (Inconclusive) 195. On an unknown date, Blood magnesium: normal (normal) normal. On an unknown date, Blood phosphorus: normal (normal) normal. On an unknown date, Blood triglycerides: 169 (Inconclusive) 169. On an unknown date, Glycosylated haemoglobin: 5.3 (Inconclusive) 5.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-163206 (Patient Link).
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Troponin
Clinical narrative: Urinary issue; Bladder tumor; This spontaneous case was reported by an other health care professional and describes the occurrence of BLADDER NEOPLASM (Bladder tumor) and URINARY TRACT DISORDER (Urinary issue) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced BLADDER NEOPLASM (Bladder tumor). On an unknown date, the patient experienced URINARY TRACT DISORDER (Urinary issue). At the time of the report, BLADDER NEOPLASM (Bladder tumor) and URINARY TRACT DISORDER (Urinary issue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-May-2021, SARS-CoV-2 test: positive positive (Positive) positive. On an unknown date, Blood cholesterol: 195 (Inconclusive) 195. On an unknown date, Blood magnesium: normal (normal) normal. On an unknown date, Blood phosphorus: normal (normal) normal. On an unknown date, Blood triglycerides: 169 (Inconclusive) 169. On an unknown date, Glycosylated haemoglobin: 5.3 (Inconclusive) 5.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-163206 (Patient Link).
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bladder neoplasm, Blood cholesterol, Blood magnesium, Blood phosphorus, Blood triglycerides
Clinical narrative: Urinary issue; Bladder tumor; This spontaneous case was reported by an other health care professional and describes the occurrence of BLADDER NEOPLASM (Bladder tumor) and URINARY TRACT DISORDER (Urinary issue) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced BLADDER NEOPLASM (Bladder tumor). On an unknown date, the patient experienced URINARY TRACT DISORDER (Urinary issue). At the time of the report, BLADDER NEOPLASM (Bladder tumor) and URINARY TRACT DISORDER (Urinary issue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-May-2021, SARS-CoV-2 test: positive positive (Positive) positive. On an unknown date, Blood cholesterol: 195 (Inconclusive) 195. On an unknown date, Blood magnesium: normal (normal) normal. On an unknown date, Blood phosphorus: normal (normal) normal. On an unknown date, Blood triglycerides: 169 (Inconclusive) 169. On an unknown date, Glycosylated haemoglobin: 5.3 (Inconclusive) 5.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-163206 (Patient Link).
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Glycosylated haemoglobin, SARS-CoV-2 test, Urinary tract disorder
Clinical narrative: Urinary issue; Bladder tumor; This spontaneous case was reported by an other health care professional and describes the occurrence of BLADDER NEOPLASM (Bladder tumor) and URINARY TRACT DISORDER (Urinary issue) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced BLADDER NEOPLASM (Bladder tumor). On an unknown date, the patient experienced URINARY TRACT DISORDER (Urinary issue). At the time of the report, BLADDER NEOPLASM (Bladder tumor) and URINARY TRACT DISORDER (Urinary issue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-May-2021, SARS-CoV-2 test: positive positive (Positive) positive. On an unknown date, Blood cholesterol: 195 (Inconclusive) 195. On an unknown date, Blood magnesium: normal (normal) normal. On an unknown date, Blood phosphorus: normal (normal) normal. On an unknown date, Blood triglycerides: 169 (Inconclusive) 169. On an unknown date, Glycosylated haemoglobin: 5.3 (Inconclusive) 5.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-163206 (Patient Link).
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dysarthria, Hemiplegia
Clinical narrative: Patient developed a large vessel occlusion (ischemic stroke) within 24 hours of receiving the first dose of the Moderna vaccine.  Stroke is cryptogenic in etiology, with consideration of hypercoagulability of malignancy as possible etiology
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ischaemic stroke
Clinical narrative: Patient developed a large vessel occlusion (ischemic stroke) within 24 hours of receiving the first dose of the Moderna vaccine.  Stroke is cryptogenic in etiology, with consideration of hypercoagulability of malignancy as possible etiology
Age: 17.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Dysgeusia, Fatigue
Clinical narrative: Hospitalization  for Cough, dyspnea and fever treated with remdesivir
Age: 17.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myalgia, SARS-CoV-2 test positive
Clinical narrative: Hospitalization  for Cough, dyspnea and fever treated with remdesivir
Age: 17.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cough, Dyspnoea, Pyrexia
Clinical narrative: Hospitalization  for Cough, dyspnea and fever treated with remdesivir
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Death
Clinical narrative: Was fine Friday, was up dancing with our family and had A LOT of energy. Then when she laid down to sleep Friday night, she had a massive stroke in her sleep. Died approximately 9:00am the 23rd.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Death, Energy increased
Clinical narrative: Was fine Friday, was up dancing with our family and had A LOT of energy. Then when she laid down to sleep Friday night, she had a massive stroke in her sleep. Died approximately 9:00am the 23rd.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations
Clinical narrative: Sixteen hours after vaccination, I was awakened with heart palpitations, which I had never had.  They lasted about one minute.  Two weeks later, at the same time, they happened again.  This continued, usually two weeks apart, always in the morning around 6:30, but a couple of times just a week apart, until the last one on May 11, 2021.  I had my second shot of Pfizer on March 4.  My doctor referred me to a cardiologist, but nothing irregular showed in the heart monitor I had taped over my heart (except palpitations one time which I forgot to press the button on the monitor), the EKG or echocardiogram.  I am worried about what might happen if I take the third shot, which I want to do.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiac monitoring, Echocardiogram normal, Electrocardiogram normal, Palpitations
Clinical narrative: Sixteen hours after vaccination, I was awakened with heart palpitations, which I had never had.  They lasted about one minute.  Two weeks later, at the same time, they happened again.  This continued, usually two weeks apart, always in the morning around 6:30, but a couple of times just a week apart, until the last one on May 11, 2021.  I had my second shot of Pfizer on March 4.  My doctor referred me to a cardiologist, but nothing irregular showed in the heart monitor I had taped over my heart (except palpitations one time which I forgot to press the button on the monitor), the EKG or echocardiogram.  I am worried about what might happen if I take the third shot, which I want to do.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Palpitations
Clinical narrative: Pt was anxious prior to vaccination.  After vaccination (1st dose) patient fainted.  When alert complained of SOB.  EMS called and pt transferred to hospital for admission.  Pt did state she had not had anything to eat that day.  Subsequently discharged 8/9/2021.